Euglycemic Diabetic Ketoacidosis Secondary to SGLT2-inhibitor Use in Combination With a Ketogenic Diet

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are cardiorenal protective agents increasingly used in patients with diabetes. Cases of euglycemic diabetic ketoacidosis (euDKA) have been reported particularly among patients with type 1 diabetes. Our case is an example that highlights the role SGL...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Hester, Joi C, Zimmerman, Stacy, Nimmo, Teresa Allison, Cunningham, Wesley, Liu, Joshua, Sukpraprut-Braaten, Suporn, Pasquel, Francisco J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Diabetes Mellitus and Glucose Metabolism
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089890/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.776
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires